Starling Oncology, Inc.

STLNW

Exchange: Nasdaq
Industry: Services-Offices & Clinics of Doctors of Medicine
SEC CIK: 0001799191

SEC filings (opens in a new tab)

In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.

Other share classesDFPH STLN

Q2 2025 vs. Q1 2025

How the institutions holding Starling Oncology, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of STLNW: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Q2 2025	Change
Holders	11	11	0
Shares	3.52M	3.81M	+288.6K (+8.2%)
Value	$94.9K	$195.4K	+$100.5K (+106.0%)

New holders (1)

Institutions that held Starling Oncology, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to STLNW in Q2 2025
Institution	Shares	Value	% of portfolio
Toronto Dominion Bank	187,674	$9.63K	0.00%

Sold out (1)

Institutions that held Starling Oncology, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of STLNW in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
FreeGulliver LLC	18,500	$501